SPOTLIGHT -
Oral Diabetes Race Comes Down to Marketing
Merck's Januvia has a head start, but Novartis isn't sitting idle.
Big Growth in Small Markets
Emerging countries are expected to drive pharma's earnings next year.
Barr to Pharma: 'Watch Out'
After winning a bidding war for Pliva, the well-positioned generic maker is giving pharma reason to worry.
